iNDI ALFAtag cell lines for the iPSC Neurodegenetive Disease Initiative (iNDI) project
ID: 75N95025Q00078Type: Sources Sought
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH NIDABethesda, MD, 20892, USA

NAICS

Biological Product (except Diagnostic) Manufacturing (325414)

PSC

IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS (6550)
Timeline
    Description

    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for the procurement of iNDI ALFAtag cell lines as part of the iPSC Neurodegenerative Disease Initiative (iNDI) project. The objective is to generate up to 230 isogenic iPSC cell lines, including fluorescent ALFAtags for visualization, adhering to established quality control standards for research on Alzheimer's disease and related dementias. This initiative is crucial for advancing scientific understanding of neurodegenerative diseases and creating a publicly accessible cell repository. Interested vendors must submit their proposals by April 15, 2025, at 12:00 PM Eastern Time, to Andrea Clay at amcgee@nih.gov, referencing solicitation number 75N95025Q00078.

    Point(s) of Contact
    Files
    Title
    Posted
    The provision 52.204-24 outlines the requirements for Offerors regarding telecommunications and video surveillance services or equipment in federal contracts. It requires Offerors to represent whether they provide or use covered telecommunications equipment or services, aligning with provisions established under the John S. McCain National Defense Authorization Act for Fiscal Year 2019. Key prohibitions include the procurement of systems that utilize covered telecommunications as a critical component, effective post the specified dates. Offerors must conduct reasonable inquiries and disclose specified information, including the entities involved, descriptions of equipment or services, and their proposed use if they affirm the use of such equipment. The document reinforces the importance of compliance and transparency regarding telecommunications technologies utilized in federal work, ensuring that only eligible entities can engage in government contracts associated with telecommunications services. This provision is vital in maintaining national security interests by preventing reliance on certain telecommunications technologies deemed risky.
    The document outlines the requirements for the representation of Offerors related to covered telecommunications equipment or services in federal contracts. It emphasizes that Offerors must define "covered telecommunications equipment or services" in accordance with clause 52.204-25, which prohibits certain telecommunications and video surveillance services. The Offeror is required to check the System for Award Management (SAM) for any excluded entities. They must then indicate whether they provide such covered services or utilize any systems that include this equipment after conducting a reasonable inquiry. The document culminates with a certification section where an authorized individual must sign and affirm their statements. This provision is critical for ensuring compliance and maintaining integrity in federal contracting processes, especially concerning national security and telecommunications standards.
    The document outlines the Federal Acquisition Regulation (FAR) clauses that contractors must adhere to in contracts involving commercial products and services. It emphasizes compliance with various legal provisions and executive orders, categorizing them into sections that specify essential clauses the contracting officer may select. Key requirements include maintaining ethical standards, ensuring fair labor practices, and respecting privacy rights. Additionally, there are clauses concerning small business participation and restrictions related to specific foreign entities. The contractor must also prepare for potential audits by the Comptroller General, ensuring access to pertinent records for transparency. The clauses integrate elements aimed at promoting small business utilization, preventing human trafficking, and fostering equitable treatment for veteran and disabled workers. Moreover, the document underscores the necessity of adhering to environmental regulations and supporting sustainable practices. Overall, this guidance serves to aid compliance within federal contracts while fostering ethical business operations and adherence to legal standards.
    This document outlines the Information and Communication Technology (ICT) Accessibility Notice for offerors responding to a solicitation from the Department of Health and Human Services (HHS). It mandates compliance with Section 508 accessibility standards, available at specified HHS resources. Offerors must submit either a HHS Section 508 Accessibility Conformance Checklist or an Accessibility Conformance Report (ACR), which detail how their ICT products and services conform to these standards. If supplies or services fail to meet these standards after contract award, the responsibility for remediation falls to the contractor. The document stipulates that all electronic content delivered must meet HHS acceptance criteria for accessibility, and materials must be accompanied by appropriate checklists, unless approved otherwise by the contracting officer. The primary goal of this notice is to ensure that all ICT offerings are accessible, thus supporting HHS's commitment to inclusivity and compliance with federal regulations.
    The document outlines the requirements for information and communication technology (ICT) accessibility in federal contracts, specifically referencing compliance with Section 508 of the Rehabilitation Act of 1973. All ICT products and services developed or acquired under such contracts must meet the Revised 508 Standards available through accessible links in the text. Should the supplied ICT fail to conform to these standards, contractors are accountable for remediation at their expense. For contract modifications that add or change ICT supplies or services, contractors must provide a completed HHS Section 508 Accessibility Conformance Checklist or an Accessibility Conformance Report based on the Voluntary Product Accessibility Template. Additionally, if the contract involves indefinite delivery types, the specifications for ICT accessibility must be clearly stated in task orders. Contractors must also communicate any perceived exceptions or exemptions related to Section 508 compliance. This clause emphasizes the government's commitment to ensuring accessibility standards are strictly observed in ICT contracting processes, reflecting broader efforts to support inclusivity in government engagements and services.
    The document outlines the invoice and payment provisions for contractors working with the federal government, specifically under the NIH. It emphasizes compliance with specific invoice requirements, including the necessary components such as vendor details, invoice numbers, contract references, and payment identification. Contractors must submit invoices through the Department of Treasury’s Invoice Processing Platform (IPP), ensuring that they meet all outlined criteria to avoid payment delays. Payment terms specify that invoices must be settled within 30 days of receipt or after government acceptance of delivered services or supplies. Additionally, there are accelerated payment provisions for small business subcontractors, mandating prompt payments post-receipt of proper invoices. Interest penalties may apply for late payments, following the Prompt Payment Act. Overall, the document serves to guide contractors in the preparation and submission of invoices while ensuring timely payments under federal contracts.
    The HHS Industry User Guide for Subcontracting Plan Reviews provides vendors with guidelines for submitting subcontracting plans necessary for HHS contracts. Vendors must log into the SBCX platform to access the Subcontracting Plan Review section. This section includes project information, subcontracting goals, supporting documents, and a notes feature for communication with HHS officials. The guide outlines steps for completing subcontracting plans: identifying plan types, reporting eligible subcontracting dollars, detailing subcontracting goal data, designating a Subcontracting Program Administrator, and including plans for involving small businesses. Vendors must certify their plans before the submission deadline, with the option to download a PDF version post-submission. The evaluation process includes review by three key approvers: the Contracting Officer, Small Business Specialist, and SBA Procurement Center Representative. This guide aids in ensuring compliance and promotes the inclusion of small businesses in federal contracting efforts, enhancing accountability in the RFP process.
    The National Institute on Aging (NIA) seeks a contractor to generate up to 230 isogenic iPSC cell lines for research on Alzheimer's disease and related dementias (ADRD) as part of the iPSC Neurodegenerative Disease Initiative (iNDI). These genetically engineered cell lines will include fluorescent ALFAtags for visualization and must adhere to quality control (QC) standards already established by the iNDI project. The contractor is tasked with developing 70 WT-ALFAtag and 160 SNV-ALFAtag cell lines, utilizing the Amaxa4D nucleofection system for editing. Deliverables include QC reports, genotyping data, and validated lead clones stored for distribution. A comprehensive report at the end of the project will document engineering methods and results from various analyses including Sanger sequencing and imaging validation. The project runs from September 30, 2025, to September 29, 2026, with the government providing a list of mutations required for engineering. The initiative aims to create a publicly accessible cell repository, enhancing understanding of mutations' effects on disease-related cells and advancing scientific research in neurodegenerative diseases.
    Similar Opportunities
    Inflammatory and Vascular Diseases Scientific Support
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to award a contract for Inflammatory and Vascular Diseases Scientific Support to Exonova Biosciences. The procurement aims to secure the services of a highly qualified scientist with extensive expertise in immunology and hereditary autoinflammatory diseases, who will contribute to the NIH's Biomedical and Metabolic Imaging Branch's research initiatives. This contract is crucial for advancing understanding in the fields of inflammation and vascular biology, particularly in relation to metabolic disorders, and is set to commence on January 1, 2026, with a performance period extending through December 31, 2026. Interested parties must respond by December 15, 2025, and can direct inquiries to Kimesha Leake at Kimesha.leake@nih.gov.
    A--Biologic Specimen and Data Repositories Information Coordinating Center (BioLIN
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking information regarding the Biologic Specimen and Data Repositories Information Coordinating Center (BioLINCC). This opportunity aims to gather insights on the capabilities and qualifications of potential contractors who can support the management and coordination of biologic specimen and data repositories. The services are critical for advancing health research and ensuring the integrity and accessibility of biological data for various studies. Interested parties can reach out to Natalie E. Bruning at natalie.bruning@nih.gov or by phone at +1 301 827 7528 for further details regarding this sources sought notice.
    Support for Evaluating and Conducting Computational and Alternative Toxicological Methods for the National Institute of Environmental Health Sciences
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institute of Environmental Health Sciences (NIEHS), is seeking proposals from small businesses to support the evaluation and conduct of computational and alternative toxicological methods. The objective of this procurement is to assist NIEHS in chemical hazard and risk assessment while minimizing the use of animal testing, focusing on areas such as population variability, developmental neurotoxicity, and carcinogenicity. This contract, which is a Cost-Plus-Fixed-Fee type, has a base period of performance from June 1, 2026, to May 31, 2027, with nine additional one-year options and a potential six-month extension. Proposals are due by December 19, 2025, and must be submitted electronically via the NIH eCPS website; interested parties can contact Jason Williams at jason.williams2@nih.gov or Lisa Schaupp at lisa.schaupp@nih.gov for further information.
    R--Repository for Osteoarthritis Initiative
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking repository services for the Osteoarthritis Initiative. The primary objective of this procurement is to engage services for the archiving, storage, maintenance, and retrieval of biological specimens associated with the initiative sponsored by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). This acquisition is crucial for ensuring the integrity and accessibility of valuable biological data that supports ongoing research in osteoarthritis. Interested parties can reach out to Derek Bowks at derek.bowks@nih.gov for further information regarding this opportunity.
    A--Study Coordinating Center for Lung Health Cohort
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking small businesses to participate in a Sources Sought notice for the establishment of a Study Coordinating Center for the Lung Health Cohort. The objective of this procurement is to identify qualified entities that can provide research and development services in the health sector, particularly focusing on lung health. This initiative is crucial for advancing understanding and treatment of lung-related health issues, which have significant implications for public health. Interested parties can reach out to Lynn M. Furtaw at lynn.furtaw@nih.gov or call +1 301 435 0330 for further information regarding this opportunity.
    The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Seeks Industry Partners for Clinical Research Collaborations on Therapeutics, Diagnostics or Devices for Childhood Cholestatic Liver Diseases
    Health And Human Services, Department Of
    The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is seeking industry partners for clinical research collaborations focused on therapeutics, diagnostics, or devices for childhood cholestatic liver diseases. The initiative aims to engage collaborators in providing novel therapeutic agents and diagnostic tools for use in NIH-sponsored multi-center clinical trials targeting conditions such as biliary atresia and alpha-one antitrypsin deficiency, among others. This collaboration is critical for advancing research and improving clinical outcomes for children suffering from these rare liver diseases. Interested organizations must submit a Capability Statement detailing their proposed solutions and capabilities, with no funding provided by NIDDK for this opportunity. For inquiries, contact Edward Doo at dooe@niddk.nih.gov or Katrina Loh at katrina.loh@nih.gov.
    GENETIC MEDICINES AND INDIVIDUALIZED MANUFACTURING FOR EVERYONE (GIVE)
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Genetic Medicines and Individualized Manufacturing for Everyone (GIVE) program. This initiative aims to revolutionize the biomanufacturing of RNA-based genetic medicines by fostering innovations in automated RNA manufacturing and integrated quality control, ultimately enabling rapid, cost-effective, and localized production in non-GMP environments. Interested parties must submit solution summaries by December 19, 2025, with full proposals due by February 27, 2026, and are encouraged to participate in a Proposers’ Day on November 13, 2025, for further insights. For additional information, please refer to the program's website or contact the designated email address.
    Support Services for Two National Information Clearinghouses
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is seeking support services for two National Information Clearinghouses. The procurement aims to provide a range of communications services, including public inquiry response, materials development and dissemination, database and website management, meeting support, graphic design, and outreach activities, all in alignment with the mission of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). These services are crucial for effectively managing and disseminating information to the public and stakeholders. Interested parties can contact Derek Bowks at derek.bowks@nih.gov or by phone at 301-594-7712 for further details regarding this opportunity.
    Biospecimen Core Resource
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) under the National Cancer Institute (NCI), is seeking to establish a Biospecimen Core Resource (BCR) to support various biospecimen-related activities. The BCR will operate under documented Standard Operating Procedures (SOPs) to facilitate the collection, processing, distribution, and storage of biospecimens as outlined in NCI Task Orders. This initiative is crucial for advancing cancer research and ensuring the integrity and availability of biospecimens for scientific studies. Interested parties can reach out to Apisit Viriya at apisit.viriya@nih.gov or Mataya Robinson at mataya.robinson@nih.gov for further details regarding this opportunity.
    Notice of Intent to Sole Source – Life Technologies Corp.
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to award a sole source contract to Life Technologies Corporation for the procurement of reagents and consumables necessary for operating Life Technologies instruments at the NIH Clinical Center's Department of Laboratory Medicine. This acquisition is critical as the reagents have been validated for specific assays, including BCR-ABL fusion, cKIT mutation, and JAK2 mutation assays, ensuring consistency in patient testing and avoiding potential delays in patient care that could arise from switching vendors. Interested parties may express their interest and capabilities to the NIH by contacting Kristin Nagashima at kristin.nagashima@nih.gov, with comments due by December 17, 2025, at 12 PM EST.